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Background. Renal cell carcinoma (RCC) metastasis to the salivary glands is extremely rare. Most cases reported previously have
involved the parotid gland and only six cases involving the submandibular gland exist in the current literature. Metastasis of RCC
to thyroid gland is also rare but appears to be more common than to salivary glands. Methods and Results.W ep r e s e n tt h eﬁ r s tc a s e
of simultaneous metastasis to the submandibular and thyroid glands from clear cell RCC in a 61-year-old woman who presented
seven years after the primary treatment. The submandibular and thyroid glands were excised completely with preservation of the
marginal mandibular and recurrent laryngeal nerves, respectively. Conclusion. Metastatic disease should always be considered in
the diﬀerential diagnosis for patients who present with painless salivary or thyroid gland swelling with a previous history of RCC.
If metastatic disease is conﬁned only to these glands, prompt surgical excision can be curative.
1.Introduction
Metastatic salivary and thyroid gland tumours are very
rare among reported clinical cases. With regards to sali-
vary gland metastasis, often the primary site of origin of
tumour is the skin or mucosal lining of the head and neck
structures, with melanomas and squamous cell carcinomas
being the most common primary tumours, respectively [1].
In metastatic thyroid tumours, the most common sites of
primary tumours are the breast, kidney, and lung, and in
some cases they are detected only at autopsy [2]. RCC is
an unpredictable tumour that can recur many years after
the original diagnosis and metastasis of this tumour to
the salivary and thyroid glands is an uncommon occur-
rence that can cause clinical and pathological problems in
diagnosis [3].
In this paper we describe a patient in whom simultane-
ous metastatic submandibular and thyroid gland tumours
occurred seven years after primary radical nephrectomy for
RCC.
2.CaseReport
A 61-year-old Caucasian female presented to her general
practitioner with painless and palpable right-sided sub-
mandibular and thyroid swellings. Her past history revealed
left mastectomy and axillary clearance with postoperative
chemoradiotherapy for grade 2 lobular breast carcinoma 2
years ago, and left radical nephrectomy for clear cell type
RCC (Fuhrman grade 2, stage pT1, completely excised with
no renal vein involvement) with no regional or distant
metastases 7 years ago. Considering her recent history of
invasive breast carcinoma, she was referred onto the breast
surgical clinic for further assessment. An ultrasound scan
(US) of her neck suggested multinodular thyroid goitre
(largest nodule in right lobe) and a well-deﬁned hypoechoic2 International Journal of Otolaryngology
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Figure 1: CT of neck with contrast. (a) Well-deﬁned tumour mass in the right submandibular gland measuring 29 × 26 × 30mm. It shows
prominent vascularisation which would be unusual for benign lesion such as PA. There is some low-density area centrally in the tumour
probably related to necrosis. (b) There is a large nodule in the thyroid on the right side measuring 26 ×23 ×30mm showing similar intense
enhancement as the submandibular lesion.
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Figure 2: (a) Original renal tumour (H&E stain, original magniﬁcation x40). On the left is normal kidney and clear cell RCC is on the right.
(b) Submandibular gland (H&E stain, original magniﬁcation x40): metastatic RCC on the top with normal glandular tissue in the lower
portion. (c) Metastatic RCC in submandibular gland (H&E stain, original magniﬁcation x200). (d) Thyroid tumour (H&E stain, original
magniﬁcation x40): tumour on the left and normal thyroid tissue on the right.
mass in the right submandibular gland. US-guided ﬁne-
needle aspiration (FNA) cytology of the right thyroid nodule
wasnondiagnosticontwoseparateoccasionsandoftheright
submandibular gland suggested a pleomorphic adenoma
(PA).
She was then seen in our otolaryngology department
where a complete ear, nose, and throat examination was
normal except for the obvious right submandibular and
thyroid gland swellings. A computed tomography (CT)
scan of her neck was performed which revealed a tumour
mass in the right submandibular gland with prominent
vascularisation unusual for benign lesions such as a PA
(Figure 1). CT scan also showed a large nodule in the right
thyroid with similar intense vascular enhancement as the
submandibular lesion (Figure 1). There was no suspicious
cervical lymphadenopathy. A bone scan showed no osseous
metastases and chest X-ray revealed no pulmonary metas-
tases.
Initially the right submandibular gland was excised
revealing an encapsulated tumour within the glandular
tissue. A right level I and II neck dissection was also
performed with preservation of the marginal mandibular
nerve. Histopathological examination of the tumour showed
striking similarity totheclearcellRCC ofleftkidney resected
previously (Figure 2). The diagnosis was further supported
by immunohistochemical ﬁndings that showed positiveInternational Journal of Otolaryngology 3
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Figure 3: Macroscopic specimens showing metastatic RCC within the submandibular (a) and thyroid (b) glands. Solid metastatic tumours
can be seen to be surrounded by normal glandular tissue in both cases without any extraglandular extension.
staining for vimentin, CD10, low molecular weight cytoker-
atins, epithelial membrane, and RCC antigens, and negative
for carcinoembryonic antigen (CEA), S100, and CD34. Sub-
sequently the patient’s case was discussed at the combined
surgical oncology and pathology meeting, and due to the
suspicious nature of the thyroid gland, a total thyroidectomy
was performed with preservation of the recurrent laryngeal
nerves and parathyroid glands. Histopathological analysis of
right lobe of thyroid gland conﬁrmed metastatic clear cell
RCC similar to the submandibular gland disease (Figure 2).
As there was no extracapsular spread and no lymphatic
disease, no further adjuvant therapy was given to the patient.
At 6-month postoperative followup, the patient showed no
signs of recurrence or other metastases.
3. Discussion
In adults, RCC constitutes approximately 2%-3% of all
malignanciesrepresenting85%ofallprimaryrenaltumours,
and its incidence increases with age, with a peak in the
s i x t hd e c a d eo fl i f e[ 4, 5]. These tumours constitute a
group of epithelial tumours that are highly heterogeneous,
consistingofseveralhistologicalsubtypesdemonstratingdif-
ferent biological proﬁles and clinical behaviour [5, 6]. Clear
cell RCC is the most commonly occurring, predominantly
associated with mutations involving the von Hippel-Lindau
gene and elaboration of vascular and somatic factors; thus
these tumours typically exhibit hypervascularity at imaging
[6]. These cancer cells are also known to have a good
adaptive potential in a diverse array of microenvironments,
thus giving rise to a high metastatic potential of RCC [1].
After nephrectomy for earlier stages of RCC, up to 50% of
patients develop recurrent or metastatic disease, with 85% of
recurrences occurring within 3 years after primary resection
but being reported up to several decades later [7].
The most frequent sites for RCC metastasis are the lung,
bone, liver, adrenal gland, contralateral kidney, retroperi-
toneum, brain, and skin [1, 7]. Metastatic RCC to the
head and neck region is less common, comprising only
8%–14% of all cases, with thyroid gland being the most
commonsite[1].Althoughuncommon,morethan150cases
of clinically recognized metastatic renal cell carcinoma to
the thyroid have been reported in the English literature.
Most cases of metastatic thyroid tumours originate from
primary renal tumours [8]. Metastatic disease from the
kidney to the thyroid gland can occur more than 20 years
after nephrectomy with the average time interval being 7.5
years [9].
Metastasis of RCC to the major salivary glands is
extremely rare. Our search only found a handful of reported
cases with a predominance of parotid gland metastases.
Based on our search, only six cases of RCC metastasis to
the submandibular gland exist in the current literature (one
of the six reports describes RCC metastasis to Wharton’s
duct) [10]. Our case is unique with simultaneous solitary
metastases within the submandibular and thyroid glands,
surrounded by normal glandular tissue, with no evidence of
extraglandular extension (Figure 3). We cannot speculate a
pathogenetic mechanism to explain this phenomenon at this
stage.
Radiologically it is diﬃcult to distinguish between
metastatic and primary malignant neoplasms [1, 7]. In our
case, US scan and FNA were suggestive of benign disease
in both sites (multinodular goitre and PA). It is the clinical
suspicion of malignancy leading to CT scanning of the
patient’s neck that raised further suspicion of a malignant
process, thus the surgical excision of the submandibular and
thyroid glands. One of the most important issues is to dif-
ferentiate metastatic RCC from other submandibular gland
neoplasmsandprimaryclearcellthyroidneoplasms. Theuse
of periodic-acid Shiﬀ (PAS) with enzymes, such as diastase
and mucin stains, is helpful in distinguishing primary
submandibular gland tumours which may have clear cell
areas, such as acinic cell and mucoepidermoid carcinomas
from RCC [1]. Generally, RCC contains glycogen, making it
PAS positive and diastase negative; on the other hand, acinic
cell carcinoma and mucoepidermoid carcinoma are revealed
as PAS positive and contain diastase-resistant material [1].
Mucin stains will aid in the diagnosis of mucoepidermoid
carcinoma. In the case of clear cell thyroid gland tumours,
the use of thyroglobulin immunohistochemistry can help to
distinguish from metastatic RCC [11].
Inaddition,RCCshowsimmunohistochemicallypositive
staining with low molecular weight cytokeratins, CD10,4 International Journal of Otolaryngology
vimentin, and RCC antigen, and CEA negativity [12]. In our
case, the neoplastic cells showed positive immunostaining
for vimentin, low molecular weight cytokeratins, CD10,
and RCC antigen but were immunonegative for CEA, thus
conﬁrming the diagnosis of metastatic RCC.
4. Conclusion
Metastatic disease should always be considered in the
diﬀerential diagnosis for patients who present with painless
salivary or thyroid gland swelling with a previous history
of renal cell carcinoma. Ultrasound and cytological ﬁndings
may not always reﬂect the actual pathology and therefore
further imaging is paramount in such circumstances. If
metastatic disease is conﬁned to these glands only, prompt
surgical excision can be curative.
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